AGÕæÈ˹ٷ½

STOCK TITAN

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company specializing in data-driven medicine, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before U.S. markets open. The company will host a conference call to discuss the results and business outlook at 8:00 a.m. EDT / 2:00 p.m. CET on the same day. Investors can access the live webcast through the SOPHiA GENETICS Investor Relations Website, where a replay will also be available after the event.

SOPHiA GENETICS (Nasdaq: SOPH), un'azienda software nativa cloud specializzata nella medicina basata sui dati, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 6 maggio 2025, prima dell'apertura dei mercati statunitensi. La società terrà una conference call per discutere i risultati e le prospettive aziendali alle 8:00 EDT / 14:00 CET dello stesso giorno. Gli investitori potranno seguire la diretta streaming sul sito web delle Relazioni con gli Investitori di SOPHiA GENETICS, dove sarà disponibile anche una registrazione dopo l'evento.

SOPHiA GENETICS (Nasdaq: SOPH), una empresa de software nativa en la nube especializada en medicina basada en datos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 6 de mayo de 2025, antes de la apertura de los mercados estadounidenses. La compañía realizará una conferencia telefónica para discutir los resultados y las perspectivas comerciales a las 8:00 a.m. EDT / 2:00 p.m. CET del mismo día. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de SOPHiA GENETICS, donde también estará disponible una repetición después del evento.

SOPHiA GENETICS (나스ë‹�: SOPH)ëŠ� ë°ì´í„� 기반 ì˜ë£Œì—� 특화ë� í´ë¼ìš°ë“œ 네ì´í‹°ë¸Œ 소프트웨ì–� 회사ë¡�, 2025ë…� 1분기 재무 ì‹¤ì  ë°œí‘œë¥� 2025ë…� 5ì›� 6ì� 미국 시장 개장 ì „ì— ì˜ˆì •í•˜ê³  있습니다. 회사ëŠ� ê°™ì€ ë‚� 오전 8ì‹� EDT / 오후 2ì‹� CETì—� 실ì ê³� 사업 ì „ë§ì—� 대í•� ë…¼ì˜í•˜ëŠ” 컨í¼ëŸ°ìФ ì½œì„ ì§„í–‰í•� 예정입니ë‹�. 투ìžìžë“¤ì€ SOPHiA GENETICS 투ìžìž� ê´€ê³� 웹사ì´íЏë¥� 통해 ìƒì¤‘ê³„ì— ì ‘ì†í•� ìˆ� 있으ë©�, 행사 종료 í›� 다시보기 ì˜ìƒë� 제공ë©ë‹ˆë‹�.

SOPHiA GENETICS (Nasdaq : SOPH), une entreprise de logiciels cloud-native spécialisée dans la médecine basée sur les données, a prévu d’annoncer ses résultats financiers du premier trimestre 2025 le 6 mai 2025, avant l’ouverture des marchés américains. La société organisera une conférence téléphonique pour discuter des résultats et des perspectives commerciales à 8h00 EDT / 14h00 CET le même jour. Les investisseurs pourront accéder à la diffusion en direct via le site des relations investisseurs de SOPHiA GENETICS, où un replay sera également disponible après l’événement.

SOPHiA GENETICS (Nasdaq: SOPH), ein Cloud-natives Softwareunternehmen, das sich auf datengetriebene Medizin spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 6. Mai 2025 vor Markteröffnung in den USA geplant. Das Unternehmen wird am selben Tag um 8:00 Uhr EDT / 14:00 Uhr MEZ eine Telefonkonferenz abhalten, um die Ergebnisse und die Geschäftsaussichten zu besprechen. Investoren können das Live-Webcast über die Investor-Relations-Website von SOPHiA GENETICS verfolgen, wo auch eine Aufzeichnung nach der Veranstaltung verfügbar sein wird.

Positive
  • None.
Negative
  • None.

BOSTON ²¹²Ô»åÌý¸é°¿³¢³¢·¡, Switzerland, April 22, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter 2025 before U.S. markets open on Tuesday, May 6, 2025. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the . Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM� Platform, a cloud-native platform that analyzes complex multimodal data � including genomics, radiomics, clinical, biological, and digital pathology data � to generate real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit  and connect with us on .

Cision View original content to download multimedia:

SOURCE SOPHiA GENETICS

FAQ

When will SOPHiA GENETICS (SOPH) release Q1 2025 earnings?

SOPHiA GENETICS will release Q1 2025 earnings on Tuesday, May 6, 2025, before U.S. markets open.

What time is SOPHiA GENETICS (SOPH) Q1 2025 earnings call?

The earnings call is scheduled for 8:00 a.m. EDT / 2:00 p.m. CET on May 6, 2025.

How can I listen to SOPHiA GENETICS (SOPH) Q1 2025 earnings call?

The call will be webcast live on the SOPHiA GENETICS Investor Relations Website, with a replay available after the event.

What will SOPHiA GENETICS (SOPH) discuss in their May 6 conference call?

The company will discuss their Q1 2025 financial results and business outlook during the conference call.
Sophia Genetics Sa

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Latest SEC Filings

SOPH Stock Data

211.16M
62.47M
6.53%
58.87%
0.05%
Health Information Services
Healthcare
Switzerland
Rolle